GT Biopharma, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2010
Total Assets: $185.0K
Liabilities Breakdown FY2010
Total Liabilities: $5.7M
Asset Breakdown
Total Assets: $185.0K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $54.0K | 29.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $48.0K | 25.9% |
| Other Assets | $83.0K | 44.9% |
Liabilities Breakdown
Total Liabilities: $5.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $625.0K | 11.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.0M | 88.9% |